Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

Workers pack vaccine doses during visit by King Philippe of Belgium at Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

Pfizer workers empty vaccine fridge during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

Workers pack vaccine doses during visit by King Philippe of Belgium at Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium visits the fridges zone during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

Pfizer workers empty vaccine fridge during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) visits the vaccine packaging area during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

Workers pack vaccine doses during visit by King Philippe of Belgium at Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

Pfizer workers empty vaccine fridge during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium visits the fridges zone during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) and Manager Director of Pfizer Puurs, Luc Van Steenwinkel (R) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs , Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (not seen) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium visits the fridges zone during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) visits the vaccine packaging area during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (R) is welcomed by Manager Director of Pfizer Puurs Luc Van Steenwinkel (L) during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (R) is welcomed by Manager Director of Pfizer Puurs Luc Van Steenwinkel (L) during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (R) is welcomed by Manager Director of Pfizer Puurs Luc Van Steenwinkel (L) during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium attends a meeting during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

Workers pack vaccine doses during visit by King Philippe of Belgium at Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

Workers pack vaccine doses during visit by King Philippe of Belgium at Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

BELGIUM, PUURS, MAR. 30, 2021 - King Philippe / Filip of Belgium visits the Pfizer-BioNTech vaccine production site in Puurs. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/ Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)